SC: Courts Must Curb Unlicensed Money Lenders; Probes Need Not Wait For New Law  ||  SC: Gratuity May be Withheld While Criminal or Disciplinary Proceedings are Pending Against Employee  ||  SC: Weapon Recovery Useless Without Proof Linking it to Crime under Section 27 Evidence Act  ||  SC: Fines Also Run Concurrently When Sentences For Multiple Offences Run Concurrently  ||  SC Dissolves 10-Year Estranged Marriage, Quashes 80+ Cases in 'Matrimonial Mahabharata' Dispute  ||  SC: Board Resolution Signature Alone Doesn’t Prove Director’s Knowledge of Company Affairs  ||  Raj HC: Industrial Tribunal Allowing Workman Legal Representation But Denying Employer is Unequal  ||  Karnataka HC: Service Bonds Enforceable on Students With Subsidised Education, Not Bonded Labour  ||  Gauhati HC: Challenge to Marks Barred by Constructive Res Judicata When Party Accepts Limited Remand  ||  SC: Cheque Dishonour Complaint Can't be Quashed Pre-Trial if Sec 138 NI Act Conditions Met    

Delhi HC Issues Notice in PIL Seeking Selling of Remdesivir by All Pharma Firms in Domestic Market - (04 May 2021)

CIVIL

Delhi High Court has issued notice to the Centre and various pharma majors asking them to respond to a Public Interest Litigation seeking that all drug firms involved in the making Remdesivir be allowed to sell it in the domestic market. The Court has issued the notice to the Health Ministry, Central Drugs Standard Control Organisation, Director General of Foreign Trade, and various pharma companies, like Cipla, Zydus, and Cadila, seeking their stand on the issue.

Tags : DELHI HIGH COURT   SELLING OF REMDESIVIR  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved